This document contains the proceedings of a hearing held on May 16, 2000, before the U.S. House of Representatives Subcommittee on Early Childhood, Youth, and Families. The hearing addressed issues and concerns on the use of ritalin among youth with attention deficit hyperactive disorder (ADHD). Following opening remarks of the congressmen, the report includes the testimony of Terrance Woodworth, the Deputy Director of the Office of Diversion Control at the Drug Enforcement Administration. In his testimony, he describes the increases in the production, distribution, and use of methylphenidate, and the lax handling of medication at schools that has provided an opportunity for abuse. The testimony of Dr. Lawrence Diller, a behavioral pediatrician, follows and addresses the over-prescription of ritalin. The testimony of special educator Francisca Jorgensen is then provided. She discusses a child with ADHD, who, after several unsuccessful educational accommodations, was provided with ritalin. Using ritalin, the student was able to attend, pay attention, and better relate to his peers. Following her testimony, the testimony of Mary Robertson, a mother of two children with attention deficit hyperactivity disorder, is provided. She discusses the benefits of ritalin. The appendices include official statements from the congressmen, witnesses, and interested parties. (CR)